Nephros (NEPH) Capital Expenditures (2010 - 2022)

Nephros' Capital Expenditures history runs 6 years deep, the most recent figure standing at $103000.0 for Q2 2022.

• On a quarterly basis, Capital Expenditures changed N/A year-over-year to $103000.0 in Q2 2022; TTM through Sep 2024 was $103000.0, a N/A change from a year earlier, with the FY2024 full-year figure at $55000.0, down 26.67% from the prior year.
• Capital Expenditures climbed to $103000.0 in Q2 2022 per NEPH's latest filing, from $34000.0 in the prior quarter.
• Across five years, Capital Expenditures topped out at $103000.0 in Q2 2022 and bottomed at $13000.0 in Q3 2020.
• The 3-year median for Capital Expenditures is $23000.0 (2021), against an average of $37200.0.
• Across the five-year window, Capital Expenditures changed 0.0% in 2021 and jumped 47.83% in 2022, its largest moves.
• Year by year, Capital Expenditures stood at $13000.0 in 2020, then changed by 0.0% to $13000.0 in 2021, then soared by 692.31% to $103000.0 in 2022.
• Per Business Quant, the three latest NEPH Capital Expenditures figures stand at $103000.0 (Q2 2022), $34000.0 (Q1 2022), and $13000.0 (Q3 2021).